Wells Fargo & Company Yumanity Therapeutics, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.5 - $1.87 $3,807 - $4,746	-2,538 Reduced 97.77%	58 $0
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.99 $2,612 - $5,096	2,561 Added 7317.14%	2,596 $5,000
Q3 2021 Nov 15, 2021	BUY	$8.3 - $12.04 $174 - $252	21 Added 150.0%	35 $0
Q2 2021 Aug 16, 2021	SELL	$11.27 - $19.64 $11 - $19	-1 Reduced 6.67%	14 $0
Q1 2021 May 13, 2021	SELL	$16.69 - $22.52 $48,117 - $64,925	-2,883 Reduced 99.48%	15 $0

Q4 2020 Feb 09, 2021	BUY	$16.67 - $25.4 $48,309 - $73,609	2,898 New	2,898 $50,000

Ticker YMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,856,500
Description
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, mu...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.